Goodwin Procter advised a syndicate of investors on the deal. Bird & Bird advised SparingVision. SparingVision, a genomic medicines company with a mission to translate pioneering...
SparingVision’s €75 Million Series B Financing
Code Biotherapeutics’ $75 Million Series A Financing
Morrison Foerster advised New Enterprise Associates, 4BIO Capital, and UPMC Enterprises on the deal. New Enterprise Associates, 4BIO Capital, and UPMC Enterprises acted as investors in...